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Background: Previous studies showed that TNF-α could activate voltage-gated Na+ channels (VGSCs) in the peripheral
nervous system (PNS). Since TNF-α is implicated in many central nervous system (CNS) diseases, we examined potential
effects of TNF-α on VGSCs in the CNS.
Methods: Effects of TNF-α (1–1000 pg/mL, for 4–48 h) on VGSC currents were examined using whole-cell voltage
clamp and current clamp techniques in primary culture of mouse cortical neurons. Expression of Nav1.1, Nav1.2,
Nav1.3, and Nav1.6 were examined at both the mRNA and protein levels, prior to and after TNF-α exposure.
Results: TNF-α increased Na+ currents by accelerating the activation of VGSCs. The threshold for action potential
(AP) was decreased and firing rate were increased. VGSCs were up-regulated at both the mRNA and protein levels. The
observed effects of TNF-α on Na+ currents were inhibited by pre-incubation with the NF-κB inhibitor BAY 11–7082 (1 μM)
or the p38 mitogen-activated protein kinases (MAPK) inhibitor SB203580 (1 μM).
Conclusions: TNF-α increases Na+ currents by accelerating the channel activation as well as increasing the expression of
VGSCs in a mechanism dependent upon NF-κB and p38 MAPK signal pathways in CNS neurons.
Keywords: Tumor necrosis factor-alpha, Voltage-gated sodium channels, Cortical neurons, Patch-clamp recording,
Neuronal excitabilityIntroduction
Tumor necrosis factor-alpha (TNF-α) is a prototypic
pro-inflammatory cytokine of the innate immune system
[1]. Upon binding to TNFR1 or TNFR2 in the brain,
TNF-α modulates a variety of fundamental physiological
processes of the central nervous system (CNS), including
synapse formation and regulation, neurogenesis, and re-
generation [2, 3]. TNF-α is also implicated in many
pathological processes and diseases of the CNS, including
gliosis, demyelination, blood–brain-barrier deterioration,
and cell death [3].
TNF-α inhibits sustained K+ channel currents in rat
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[5]. Voltage-gated Na+ channels (VGSCs) consist of
pore-forming α-subunits (220–260 kDa) and auxiliary
β-subunits (32–36 kDa) [6]. VGSCs regulate the propaga-
tion and regeneration of action potential (AP) [7–10].
TNF-α enhances Na+ currents in dorsal root ganglion
(DRG) neurons [11, 12]. Considering the implication of
TNF-α in a variety of pathological processes and diseases of
the CNS, we examined the potential effects of TNF-α on
voltage-gated Na+ currents in primary culture of mouse
cortical neurons in the current study.Materials and methods
Cortical neuron culture
The animal study complied with the guidelines for care
and use of experimental animals of the Ethics Committee
of Shantou University Medical College. Primary culture of
cortical neurons was performed using 14-day-old (E14)icle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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C57 BL/6 mice were purchased from the Shantou Uni-
versity Medical College Experimental Animal Center,
Shantou, China. Cerebral cortices (without the hippo-
campus and duramater) were trypsinized for 2 min with
4 ml of 0.25 % trypsin (Invitrogen) at 37 °C and then
interrupted with 0.5 ml of fetal bovine serum (HyClone).
Cells were collected by centrifugation for 10 min at 900×g.
The pellet was re-suspended in minimum essential medium
(Invitrogen). Cells (1 × 106) were plated onto 22 × 22 mm
poly-D-lysine-pretreated glass cover slips (Sigma) with 2 ml
culture medium at 37 °C in 5 % CO2/95 % air. Glutamine
(2 mM) and B-27 supplement (2 %) were added into
the neurobasal medium immediately before use. Half of
the culture medium was changed every 3 days. A selective
inhibitor of DNA synthesis, arabinosylcytosine C (5 μM),
was added to the medium on day 3 for 24 h to minimize
glial contamination. All experiments were performed on
days 8–12.
Electrophysiological recording
Electrophysiological recording of the cortical neurons
was performed, as previously reported [13].The neurons
were re-plated within 24 h before recording in order to
minimize space clamp artifacts. Extracellular solution for
whole-cell recording of voltage-gated Na+ currents con-
sisted of 70 mM NaCl, 70 mM choline-Cl, 5 mM KCl,
1 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, 4 mM TEA–
Cl, 0.1 mM CdCl2, and 10 mM glucose (pH adjusted to 7.3
with NaOH). Added to block Ca2+ currents was 0.1 mM
CdCl2. The pipette solution contained 145 mM CsCl,
1 mM MgCl2, 5 mM EGTA, 10 mM HEPES, and 5 mM
ATP–Na2 (pH adjusted to 7.3 with CsOH). Pipettes were
pulled using borosilicate glass capillary tubes with a P-97
micropipette puller (Sutter Instrument). Tip resistance
was 3–5 MΩ. Voltage clamp recording was performed
using an EPC-10 amplifier (HEKA). Series resistance
was compensated by 80 to 90 %. Data were digitized at
200 kHz. Neurons were held at −100 mV and depolarized
to 100 mV for 20 ms with 5-mV steps and 0.5-Hz fre-
quency. To examine the activation properties of VGSCs,
Na+ currents were recorded at 0 mV after prepulsing
from −100 to 30 mV for 40 ms with 5-mV steps to examine
the inactivation properties of VGSCs.
The threshold for APs and neuronal firing rate were
recorded in a current clamp mode. The neurons were held
at 0 pA, and APs were elicited with depolarizing currents
ranging from −50 to 70 pA (120 ms) with increments of 10
pA. The external solution contained 140 mM NaCl, 3 mM
KCl, 1 mM MgCl2, 1 mM CaCl2, 0.1 mM CdCl2 and 10
mM HEPES (pH adjusted to 7.3 with NaOH). The pipette
solution contained 140 mM KCl, 0.5 mM EGTA, 5 mM
Mg-ATP, and 5 mM HEPES (pH adjusted to 7.3 with
KOH). Added to block Ca2+ currents was 0.1 mM CdCl2.All experiments were performed at room temperature
(23–25 °C).Drug application
Tetrodotoxin (TTX; 300 nM in the bath solution of voltage
clamp experiments) was used to verify the TTX sensitivity
of the channels. In dose-finding experiments, TNF-α
(Sigma) of varying concentration (1, 10, 100, and 1000
pg/ml) was included in the medium for 24 h. For sub-
sequent experiments, cultured neurons were exposed
to TNF-α at 100 or 1000 pg/ml in 0.1 % bovine serum
albumin (BSA) in saline for 4, 8, 24, or 48 h. Neurons
were pretreated with an NF-κB inhibitor (10 μM BAY-11
7082 in 0.1 % dimethylsulfoxide) or a p38 mitogen-
activated protein kinases (MAPK) inhibitor (10 μM
SB203580 in 0.1 % DMSO) for 0.5 h before and during
TNF-α exposure (100 pg/ml 24 h) to determine whether
the activation of NF-κB and/or p38 MAPK contributes
to the TNF-α-induced enhancement of voltage-gated
Na+ currents.Total RNA extraction and reverse transcription and real-time
PCR
The NaV1.1, NaV1.2, NaV1.3, and NaV1.6 Na
+ channels
are expressed in cerebrocortex [14]. Potential changes in
these channels after TNF-α exposure were examined
at the mRNA expression level. TNFR1 expression was
examined with real-time quantitative PCR.
Total RNA was extracted using TRIzol reagent (Invitro-
gen) and reverse-transcribed to cDNA using the following
primers: Nav1.1, 5′-CATGTATGCTGCAGTTGATTCCA-
3′ (forward) and 5′-AACAGGTTCAGGGTAAAGAAGG-
3′ (reverse); Nav1.2, 5′-GCCTTGCTCCTCAGTTCTTTC
A-3′ (forward) and 5′-CGGCTATCTGGAGGTTGTTCA-
3′ (reverse); Nav1.3, 5′-GGTGTGCCTCATCTTCTGGTT
AA-3′ (forward) and 5′-TGCTGCCCGTTGTCATGTTA-
3′ (reverse); Nav1.6, 5′-CGTGACACGGTTGCATCCT-3′
(forward) and 5′-ACCGAGTGTGGAACATGCAGTA-3′
(reverse); TNF-RI,5′-CAACGTCCTGACAATGCAGACC-
3′ (forward) and 5′-ACGCATGAACTCCTTCCAGCG-3′
(reverse);GAPDH, 5′-ATCAAGAAGGTGGTGAAGCA-3′
(forward) and 5′-AAGGTG GAAGAATGGGAGTTG-3′
(reverse). A total 20-μl reaction volume contained 10-μl
SYBR Green PCR Master Mix (Applied Biosystems), 1-μl
cDNA template, and 1-μl forward/reverse primers. The
templates were amplified using the following protocol:
95 °C for 2 min, 40 cycles of 95 °C for 30 s, and 60 °C
for 1 min. TNFR1 mRNA was reverse-transcribed from
1-μg total RNA extract using Expand Reverse Tran-
scriptase (Roche) with the following primers (NM_011609;
228 bp): 5′-TCACCCACAGGGAGTAGGGCA-3′ (for-
ward) and 5′-GCCTGGCGGCGCCGCACGCCG-3′ (re-
verse). TNFR1 was amplified for 30 cycles at an annealing
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72 °C for 10 min.
Immunoblot
Membrane preparation, obtained with discontinuous su-
crose gradient centrifugation, was used to measure the
expression of the pore-forming VGSC α (SCNα) subunit.
Briefly, whole-brain lysate in 0.32 M sucrose/5 Mm Tris
(pH 7.4) was layered onto 1.2 M sucrose/5 mM Tris (pH
7.4) and then centrifuged at 10,000×g for 30 min. The
protein fraction at the 0.8/1.2 M sucrose interface was
collected, diluted twofold with 0.8 M sucrose/5 mM Tris
(pH 7.4), and then centrifuged at 20,000×g for 20 min.
Pelleted membrane proteins were re-suspended in RIPA
buffer containing 25 mM Tris, 150 mM NaCl, 1 mM
EDTA, and 2 % Triton X-100 (pH 7.4), and then centri-
fuged at 20,000×g for 20 min. The resulting supernatant
was used as membrane preparation for further analysis.
Complete Protease Inhibitor (Roche) was included inFig. 1 Concentration-dependent effects of tumor necrosis factor-α (TNF-α)
Expression of TNF-α receptor 1 in mouse cortical neurons as detected by R
100 mV in control and TTX (300 nM) treated neurons. c Typical recording c
and TNF-α-treated (100 pg/ml, 24 h) neurons. d Current density–voltage re
groups. e Concentration-dependent effects of TNF-α (1, 10, 100, and 1000
expressed as percentage of the control group. *P < 0.05 vs. the control (onall solutions. Membrane proteins (100 mg) were frac-
tionated by sodium dodecyl sulfate–polyacrylamide gel
electrophoresis, and electro-transferred onto a nitrocellu-
lose membrane (Millipore). The membrane was blocked in
5 % nonfat dry milk and then incubated with a mouse anti-
pan Nav antibody (1:200; Alomone) overnight at 4 °C.
The membrane was washed with TBS/Tween-20, incu-
bated in horseradish peroxidase-conjugated secondary
antibody (goat anti-mouse 1:1,000; Sigma), washed again
with TBS/Tween-20, and then visualized using a standard
chemiluminescence method.
Viability experiments
Ten coverslips, each containing at least 100 mouse neu-
rons, were incubated for 24 h in either control medium
(n = 5 coverslips) or medium containing 100 pg/ml
TNF-α (n = 5 coverslips), followed by staining with try-
pan blue (0.2 %) for 5 min. The number of viable cells is
expressed as a percentage of the total cell population.on voltage-gated Na+ currents in cultured mouse cortical neurons. a
T-PCR. b Original recording curves of whole-cell currents from −80 to
urves of whole-cell Na+ currents from −80 to 100 mV in the control
lationship in the control and TNF-α-treated (10 and 100 pg/ml, 24 h)
pg/ml) on Na+ currents. Data were normalized against the control and
e-way ANOVA followed by SNK test)
Chen et al. Journal of Neuroinflammation  (2015) 12:126 Page 4 of 10Statistical analysis
Data are expressed as mean ± SEM. Statistical analysis
was performed using Origin software (Origin Lab Cor-
poration, Northampton,) and SPSS 15.0 (SPSS Inc.). The
normative Na+ current amplitudes, mRNA, and protein
expression level were analyzed using two-way ANOVA
analysis with treatment and exposure time as independent
variables. The V1/2 and slope (k) of activation and inactiva-
tion were evaluated using one-way ANOVA. Threshold
for AP and firing rate of the two groups were compared
using Student’s t test. The efficiency of amplification of
the target and normalizing products ranged from 0.9~1.1
in real-time PCR. The results were calculated using the
2−(ΔΔCT) method.
Results
Concentration-dependent enhancement of Na+ currents
by TNF-α
Reverse transcription PCR revealed the presence of TNFR1
mRNA within cortical neurons (Fig. 1a). An inward current
with fast activation and inactivation was elicited by
depolarization steps from −100 mV of the holding poten-
tial and recorded at 200 kHz of the sampling frequency;
the currents under were completely blocked with TTXFig. 2 Time-dependent effects of TNF-α on Na+ currents and electrophysiolo
in the group treated with 100 and 1000 pg/ml TNF-α and control group for 2
currents ranging from 0 to 48 h. Current data were normalized by the co
compared with 0 h group, #P < 0.05 the 100 or 1000 pg/ml TNF-α-treated grou
(24 h) vs. the control group (48 h) (two-way ANOVA). c Voltage-dependent activ
TNF-α-treated (24 h) and 24 h control groups. d Voltage-dependent fast-inactiva
TNF-α-treated (24 h) and 24 h control groups(300 nM; Fig. 1b). TNF-α (1–1000 pg/ml for 24 h) en-
hanced the voltage-gated Na+ currents in a concentration-
dependent manner by 11, 41, 80, and 83 % at 1, 10, 100,
and 1000 pg/ml, respectively (Fig. 1c–e).The peak currents
(at −20 mV), plotted against TNF-α concentration (Fig. 1e),
also revealed the action is concentration-dependent.
Time-dependent enhancement of Na+ currents by TNF-α
The concentration of 100 and 1000 pg/ml was chosen
for further experiments to examine the effects of TNF-α.
TNF-α increased Na+ currents at 24 and 48 h but not
after 4 or 8 h exposure (Fig. 2a). Because of the different
datasets, the sodium current density for 100 pg/ml in
Fig. 2a is different from the one in Fig. 1d. The normative
peak current at −20 mV also revealed time-dependent in-
crease of the TNF-α action (Fig. 2b).
Effects of TNF-α on the activation and fast-inactivation of
Na+ channels
The conductance–voltage curve, fitted using the Boltz-
mann equation, is shown in Fig. 2c. Fast-inactivation,
reflected as the peak currents at 0 mV test voltage nor-
malized using the maximal current, is shown in Fig. 2d.
Normative currents were plotted to the prepulse voltage,gical characteristics of Na+ currents. a Current density–voltage relationship
4 h. b Time dependency of TNF-α (100 and 1000 pg/ml) effects on Na+
ntrol and expressed as percentage of the control group. *P < 0.05 as
p (24 h) vs. the control group (24 h), and 1000 pg/ml TNF-α-treated group
ation curves (Boltzmann equation and fitting parameters) in the 100 pg/ml
tion curves (Boltzmann equation and fitting parameters) in the 100 pg/ml











V1/2 (mV) −37.01 ± 0.46 36.07 ± 0.48 −53.07 ± 0.43 56.95 ± 0.39
*
Slope factor 2.907 ± 0.39 2.929 ± 0.42 6.528 ± 0.38 6.117 ± 0.33
V1/2 voltage of half-maximal activation or inactivation, k slope, TNF-α (100 pg/ml,
24 h)
*P < 0.001 vs. the control
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Boltzmann equation (Fig. 2d). The voltage dependence
(V1/2) and slope for both activation and steady-state inacti-
vation are shown in Table 1.
TNF-α hyperpolarized shift V1/2 of inactivation from −
53.07 ± 0.43 (n = 15) to −56.95 ± 0.39 mV (n = 19), with-
out affecting k (Table 1 and Fig. 2d). Channel activation
was not affected by TNF-α (Fig. 2c). TNF-α exposure did
not affect neuronal viability (67.9 ± 1.8 % vs. 69.3 ± 2.1 %;
P = 0.69, Mann–Whitney test).
TNF-α treatment (100 and 1000 pg/ml) markedly in-
creased the level of mRNAs for Nav1.1, Nav1.2, Nav1.3,Fig. 3 Effects of TNF-α on the expression of TNFR1 mRNA and VGSCs. Norm
and TNF-R1 (e) mRNA. The value of each group was obtained from three sep
(two-way ANOVA). f Nav channels protein expression in cortical neurons
buffer, “+”: treated with TNF-α (100 pg/ml) in PBS buffer. g The value of e
(two-way ANOVA)and Nav1.6 at 8 and 24 h but not upon shorter incubation
(Fig. 3a–d). TNF-α produced a tendency for increasing
TNFR1 mRNA at 8 and 24 h, but the results were not sta-
tistically significant at 24 h (Fig. 3e). GAPDH was used in
the present study as the reference gene because of its sta-
bility under a wide range of experimental treatments. All
these data come from three separate experiments.
Consistent with the patch-clamp experiments, immuno-
blot of Nav channels in the plasma membrane of VGSC
(Fig. 3f) showed significantly increased number of Nav
channels (by 65.88 %) after TNF-α treatment (100 pg/ml)
for 24 h (P < 0.05) (Fig. 3g).
BAY 11–7082 and SB 203580 inhibited the effects of TNF-α
on voltage-gated Na+ currents
Previous studies have reported that TNFR1 activation
mediates the effects of soluble TNF-α on various cell
processes, including gene transcription, via downstream
intracellular signaling pathways by activating the NF-ĸB
signaling complex [15] and/or p38 MAPK [16]. In our
experiments, pretreatment with either BAY 11–7082 or
SB203580 for 30 min before TNF-α treatment attenuated
the effects of TNF-α (by 98 and 37 %, respectively; Fig. 4a,ative expression level of Nav1.1 (a), Nav1.2 (b), Nav1.3 (c), Nav1.6 (d),
arate experiments done in duplicates. *P < 0.05 vs. the relevant control
were detected with western blot “−”: treated with 0.1 % BSA in PBS
ach group was obtained from three separate experiments. *P < 0.05
Fig. 4 Inhibition of NF-κB and p38 MAPK decreased the TNF-α augmentation of Na+ currents. a Typical recording curves of whole-cell Na+ currents
from −80 to 100 mV in the control and TNF-α (100 ng/ml, 24 h), TNF-α + BAY 11-7082(1 uM), and TNF-α + SB203580 (1 uM)groups. b Normalized peak
current–voltage relationship in the control and TNF-α (100 pg/ml, 24 h), TNF-α + BAY 11-7082(1 uM), and TNF-α + SB203580 (1 uM) groups. *P < 0.05
vs. the 24 h control group; #P < 0.05 vs. TNF-α (100 pg/ml, 24 h) group (one-way ANOVA followed by SNK). c Voltage-dependent activation
curves (Boltzmann equation and fitting parameters) in the TNF-α (100 pg/ml, 24 h), TNF-α + BAY 11-7082, and TNF-α + SB203580 groups.
d Voltage-dependent inactivation curves (Boltzmann equation and fitting parameters) in the TNF-α (100 pg/ml, 24 h), TNF-α + BAY 11-7082,
and TNF-α + SB203580 groups
Table 2 Effects of SB203580 and BAY11-7082 on Na+ channel kinetics in neurons treated by TNF-α
Activation Inactivation




V1/2 (mV) −31.47 ± 0.38 −29.32 ± 0.36 −29.9 ± 0.62 −55.33 ± 0.31 −54.21 ± 0.61 53.04 ± 0.34
*
Slope factor 3.553 ± 0.31 3.681 ± 0.31 4.867 ± 0.54 5.003 ± 0.27 6.380 ± 0.54 5.453 ± 0.30
V1/2 voltage of half-maximal activation or inactivation, k slope, TNF-α (100 pg/ml, 24 h)
*P < 0.001 vs. TNF-α (100 pg/ml, 24 h) group (one-way ANOVA followed by SNK)
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Fig. 5 Effects of TNF-α on spike. a, b Traces showing representative recordings of action potentials. Threshold of action potential was significantly
lower in the TNF-α group than in the control group. c Histogram showing the action potential threshold in the control and TNF-α groups,
(*P < 0.05, n = 10 in each group (Student’s t-test). d and e Representative recordings of firing rate of action potential in response to current
injection (500 pA, 1 s) in the control and TNF-α (100 pg/ml for 24 h) groups. f Histogram showing the firing rate in the control and TNF-α (100 pg/ml
for 24 h) groups. *P < 0.05, Student’s t-test (n = 8 in each group)
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of V1/2 in steady-state fast-inactivation from −55.33 ± 0.31
(n = 9) to −53.04 ± 0.34 mV (n = 8, p < 0.001, as compared
with TNF-α) (Fig. 4d and Table 2) but not activation
(Fig. 4c). SB203580 did not affect the gating properties
(either V1/2 or k) of either activation or steady-state in-
activation (Fig. 4c, d).
Effects of TNF-α on the amplitude and threshold of AP
The threshold of the spike was significantly lowered by
TNF-α (100 pg/ml, 24 h) (Fig. 5a–c). The firing rate was
increased by TNF-α (100 pg/ml, 24 h) (Fig. 5d–f ). These
results, consistent with the data from voltage clamp re-
cording, strongly indicated that TNF-α can increase the
excitability of mouse cortical neurons.
Discussion
Long-term treatment (12 h) with TNF-α enhances the
currents of VGSCs in DRG neurons following motor
nerve injury and increases the expression of Nav1.3, Nav1.6
(TTX-S) and Nav1.8 (TTX-R) [17–19]. In the present
study, we found that TNF-α could enhance voltage-gated
Na+ currents of neurons in the CNS in a time- and
concentration-dependent manner. We also showed that
TNF-α accelerates the inactivation of Na+ channels,
and the effect could be attenuated by BAY11-7082, aNF-ĸB inhibitor. The increased VGSC function was as-
sociated with increased expression of VGSCs at both
the mRNA and protein levels. Effects of TNF-α on Na+
currents were apparently dependent on NF-κB and p38
MAPK signaling pathways. Together with previous re-
ports, these results indicated an important role of the
pro-inflammatory cytokine of TNF-α in neuron excitability.
Na+ currents increased only after 24 h, but not earlier,
after TNF-α exposure in our experiments. In a preliminary
set of acute experiments (5-min exposure), TNF-α in-
creased Na+ channels only at 10,000 pg/ml but not the
concentrations (100 and 1000 pg/ml) used in the experi-
ments (hours of incubation, as described earlier). While
previous work found that bath application of a mouse
recombinant TNF-α (100 ng/ml) could rapidly enhance
peak TTX-R Na+ currents (within 3–5 min) in DRG neu-
rons in a concentration-dependent manner at 20–100
ng/ml [17]. The obvious differences in the required
concentration of TNF-α may be dependent on the sub-
types of VGSCs and neurons.
In our results (Fig. 2c), TNF-α appears to increase per-
sistent sodium currents, which likely resulted from en-
hanced expression of Nav1.6 channels. Nav1.6 channel is
known to be capable of producing persistent sodium
current which can affect firing threshold and sustained
firing [20, 21]. While the persistent Na+ current is typically
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critical role in firing regulation. Persistent Na+ currents
cause the activation of a subthreshold plateau potential
and helped initiate each spike and maintain depolarization
of membrane potential near threshold permitting firing.
Therefore, it is possible that TNF-α elevates neuronal ex-
citability via enhanced persistent Na+ currents.
Among the multitudinous cytokines produced by im-
mune cells (microglia) in the brain, TNF-α is a central
mediator of inflammation, immune response, and anti-
viral defense [22]. Both neurotoxic and neuroprotective
effects have been attributed to TNF-α in the CNS, pos-
sibly due to activation of different TNF-α receptors [16,
23]. TNFR1 is constitutively expressed on variety of cell
types, including neurons in brain [24], whereas TNFR2
is highly regulated and is typically found on microglia
and endothelial cells [25]. Consistent with previous studies,
we confirmed the presence of TNFR1 but not TNFR2 in
cortex neurons by real-time PCR and immunofluorescence
(data not shown).
Soluble TNF-α exerts its effects mainly through TNFR1
[15], and TNFR1 signaling is functionally important for
homeostatic process in CNS [26]. TNF-α can potentiate
excitotoxicity by potentiating glutamate excitotoxicity and
inhibiting glial glutamate transporters through TNFR1
signal on astrocytes [27, 28]. In the present study, TNF-α
increased Na+ current density and generation of Aps,
suggesting TNFR1 likely directly potentiates excitotoxicity
by enhancing functional voltage-gated sodium channels in
cortex neurons.
The activation of many pivotal signal pathways (including
p38 MAPK pathway and NF-κB pathway) by TNF-α in the
CNS is mediated by TNFR1 [2]. The p38 MAPK signal
pathway seemingly has a multiple and contradictory roles
in Na+ currents in neurons. Earlier studies document that
TNF- α enhanced the currents of VGSCs in DRG neurons
and increases the expression of Nav1.3, Nav1.6, and Nav1.8
after 12-h treatment [17–19]. Similarly, in this study, a
chronic exposure (24 h) of neurons to TNF-α induced an
apparent increase of Na+ currents by increasing VGSC
mRNA and protein levels. In our experiments, potentiation
of TNF-α was blocked by the p38 MAPK inhibitor
SB203580, possibly by inhibiting constitutive p38 MAPK
activation as reported earlier in normal neurons [29]. In
contrast, acute exposure (within 1 h) of TNF-α enhances
TTX-R (Nav1.8) Na+ currents by p38-mediated modula-
tion in sensory neurons and DRG neurons [17, 19], due to
p38 MAPK-mediated phosphorylation of serine residues
within L1 of the channel. Wittmack and Gasser independ-
ently found that acute activation of p38 leads to a signifi-
cant reduction in the peak Nav1.6 current amplitude in
the neuronal ND7/23 cell line and native hippocampal
neurons by phosphorylation of specific polypeptide motif
within L1 of Nav1.6 [29, 30]. For both Na+ current increasein TTX-R VGSCs and reduction in TTX-S VGSCs, the
underlying mechanism is based on p38 MAPK-mediated
phosphorylation of the channels. Such a mechanism is
apparently distinct from what happens upon prolonged
exposure to TNF-α: p38 MAPK-mediated Na+ current
enhancement by increasing the channel synthesis. To-
gether with these previous results, the regulation of VGSC
by p38 MAPK that we report in this study demonstrates
that the mechanism of p38 MAPK-mediated voltage gated
Na+ channels regulation dependent on exposure duration
and the type of the neurons.
Earlier study confirmed that the phosphorylated forms of
IKK-1, IKK-2, and IκB-α are concentrated within the axon
initial segment (AIS) and the node of Ranvier [31]. These
axon potential generating regions are rich in membrane-
embedded voltage-gated sodium channels. In the present
study, chronic exposure of TNF-α induced NF-κB activation
associating with enhancive Na+ currents by increasing
voltage-gated sodium channels expression. The important
roles of NF-κB in modulation of voltage-dependent calcium
channels by TNF-α have also been reported in cultured rat
hippocampal neurons [32]. Furthermore, inhibition of NF-
κB attenuated the shift of V1/2 of inactivation induced by
TNF-α, investigating that NF-κB is involve with VGSC dy-
namic property. In contrast, both the current study and pre-
vious reports [29, 30] showed that the p38 MAPK inhibitor
SB203580 does not affect the activation and inactivation.
In summary, we showed that TNF-α enhances the activity
of VGSCs in cultured mouse cortical neurons in a time- and
concentration-dependent manner. This enhancement is as-
sociated with the alteration of channel properties as well as
upregulation of VGSCs. The effects were likely dependent
on the TNFR1-mediated NF-κB and p38 MAPK signaling
pathways. Our findings encourage further studies to exam-
ine the effect of TNF-α in the brain in the context of excito-
toxicity induced by inflammatory and CNS diseases.
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